Indications for Carotid Endarterectomy (CEA)

1. Symptomatic Carotid Stenosis

a) Severe Stenosis: 70-99%

• Strongest indication - CEA is clearly recommended
• NASCET showed a 16.5% absolute risk reduction in stroke at 2 years (surgical stroke/death rate: 5.8%)
• ECST confirmed 9.6% absolute risk reduction at 3 years for 70-99% stenosis
• AHA guideline: CEA is recommended if the perioperative stroke/death rate is ≤6%
• Maximum benefit is gained if surgery is performed within 2 weeks of the TIA or minor stroke (meta-analysis by Rothwell et al., 2004)

b) Moderate Stenosis: 50-69%

• CEA is recommended after consideration of patient-specific factors (age, comorbidities, symptom severity)
• NASCET showed a more modest 10.1% absolute risk reduction at 5 years
• SVS and AHA guidelines support CEA in this group with appropriate patient selection

c) Stenosis <50%

• CEA is not indicated - no benefit demonstrated; medical therapy alone is preferred

Symptomatic Presentations That Qualify

• TIA - transient focal neurologic deficit resolving within 24 hours
• Amaurosis fugax (transient monocular blindness)
• Minor ischemic stroke with good neurologic recovery
• Crescendo TIAs (increasing frequency with full resolution between attacks)
• Stroke-in-evolution in selected cases

2. Asymptomatic Carotid Stenosis

Stenosis ≥60% (or ≥70% by some guidelines)

• ACAS demonstrated benefit of CEA + medical therapy vs. medical therapy alone for 60-99% asymptomatic stenosis (5.9% absolute risk reduction at 5 years; p = 0.004)
• ACST (Europe) confirmed: 5.4% absolute risk reduction at 5 years (p < 0.0001)
• SVS guidelines: CEA should be "considered" for asymptomatic stenosis ≥70% with reasonable life expectancy (3-5 years) and a surgical stroke/death rate <3%
• AHA guidelines: CEA for 60-99% asymptomatic stenosis if perioperative stroke/death rate is ≤3%

Summary Table: Landmark Trial Data

3. Special Considerations

Contralateral Disease

• Patients with bilateral carotid disease have a higher stroke risk (~69% at 2 years without surgery vs. ~22% with surgery on the symptomatic side)
• CEA on the symptomatic side is still beneficial even with contralateral disease

Timing

• For symptomatic patients, surgery within 2 weeks of TIA or minor stroke offers maximum benefit
• For acute stroke with complete carotid occlusion, surgical timing is more controversial

Non-stenotic Ulcerated Plaques

• CEA may be considered in select cases of symptomatic, non-stenotic but heavily ulcerated plaque, as an embolic source

4. Contraindications / Increased-Risk Situations for CEA

• Hostile neck anatomy (prior neck dissection, radiation)
• Tracheostomy (increased infection risk)
• Contralateral laryngeal nerve palsy
• Lesion extending above C2 (difficult surgical exposure)
• Inability to tolerate general or regional anesthesia
• Complete carotid occlusion (CEA not applicable)
• Stenosis <50% (no RCT evidence of benefit)

• Current Surgical Therapy 14e, "Indications for CEA" (NASCET, ECST, ACAS, ACST trial data and SVS/AHA guidelines)
• Sabiston Textbook of Surgery, CEA chapter
• Adams and Victor's Principles of Neurology, 12th ed., Carotid Endarterectomy section
• Mulholland & Greenfield's Surgery 7e, CEA chapter

CEA in Acute Major Stroke and Complete Carotid Occlusion

Part 1: CEA After Acute Major Stroke

The Core Problem - Hemorrhagic Transformation

• Earlier studies showed increased stroke exacerbation and hemorrhagic transformation when CEA was performed within 5-6 weeks after acute stroke
• BBB abnormalities persist for up to 4 weeks after infarction; histologic resolution of large infarcts takes several months
• In a large retrospective analysis, risk of death within 30 days of surgery was greatest in the first 3 months post-stroke, and the increased risk did not stabilize until 9 months

Who Can Have Early CEA After Stroke?

Timing Dilemma: Why Not Just Wait?

• 12% risk of a second stroke within 4 weeks of the first stroke
• Risk of the stenotic segment progressing to complete occlusion (which then eliminates the surgical option entirely)
• Early CEA may restore perfusion to the ischemic penumbra, potentially improving long-term functional recovery

Emergency Surgery After Acute Stroke

• Surgery between 3-14 days post-stroke carried the greatest cardiac event risk
• Paradoxically, surgery within 3 days (emergency) had less risk than the 3-14 day window
• This suggests: if emergency surgery is genuinely necessary, there may be no benefit to a brief delay

Part 2: CEA for Complete (100%) Carotid Occlusion

General Rule: CEA is NOT Performed

1. Embolic risk - the procedure risks dislodging thrombus that has propagated above the occlusion, sending emboli intracranially
2. No proven benefit - no RCT evidence supports CEA for established complete occlusion

The One Exception: Emergent CEA for Acute Complete Occlusion

"A patient with new neurologic deficit and an angiographically confirmed complete carotid occlusion contralateral to the symptoms should be considered for emergent CEA."

• Surgery must be performed within 2 hours of symptom onset
• Must not be performed on obtunded or comatose patients
• These restrictions mean very few patients actually qualify

Complete Asymptomatic Occlusion

• No treatment needed if there is no neurologic deficit
• Adequate collateral flow via the anterior and posterior communicating arteries may render the occlusion entirely silent
• Medical therapy (antiplatelet, statins, risk factor control) is the management

Intracranial Carotid Occlusion - Alternative: Endovascular Thrombectomy

Summary

• Neuroanatomy through Clinical Cases, 3rd ed., KCC 10.5
• Schwartz's Principles of Surgery, 11th ed., Treatment of Carotid Occlusive Disease
• Miller's Anesthesia, 10th ed., Deferring Elective Procedures After Stroke
• Tintinalli's Emergency Medicine, Endarterectomy section
• Current Surgical Therapy 14e, CEA Indications

Sex Differences in Carotid Endarterectomy

1. Benefit from CEA: Symptomatic Disease

High-Grade Stenosis (70-99%) - Benefit is Similar in Both Sexes

• Bradley and Daroff's Neurology: "Benefits of CEA are similar for men and women for high-grade carotid stenosis"
• This is the one area where sex does not significantly change the recommendation

Moderate Stenosis (50-69%) - Women Benefit Less

• Bradley and Daroff's: "Women with either asymptomatic or moderate (50%-69%) symptomatic carotid artery disease seem to derive a less clear benefit from CEA as opposed to men" (Chaturvedi et al., 2005)
• Harrison's (22nd ed.): A meta-analysis of NASCET and ECST data confirmed that men appear to benefit more than women overall
• The lower absolute stroke risk in women with similar stenosis degrees partially explains this: if the untreated risk is lower, the net gain from surgery shrinks

2. Benefit from CEA: Asymptomatic Disease - The Most Controversial Area

ACAS and ACST Data on Women

• In ACAS, subgroup analysis could not demonstrate a significant benefit for women with asymptomatic stenosis ≥60%
• In both ACAS and ACST, the perioperative complication rate was higher in women, which may have entirely negated any stroke reduction benefit within the 5-year follow-up window
• Harrison's: "At present, carotid endarterectomy in asymptomatic women remains particularly controversial"
• Adams and Victor's Neurology: ACST concluded "endarterectomy may be justified for asymptomatic carotid stenosis of this degree in men (not so in women)" - though requiring audited surgical risk below 3%

Why Asymptomatic Women May Not Benefit

• Women with asymptomatic carotid stenosis have a lower natural history stroke rate than men with comparable stenosis degrees
• Asymptomatic bruits in men (but not women) have historically carried a higher stroke risk in population studies
• The small absolute benefit in asymptomatic disease is easily wiped out by even modestly higher perioperative risk

3. Perioperative Risk

Women Have Higher Perioperative Complication Rates

• Textbook of Family Medicine 9e: "Women have higher rates of perioperative complications than men"
• This has been consistently observed across trials and registries

Microembolization

• Miller's Anesthesia: "Perioperative microembolization is more common in women and patients with symptomatic carotid disease" - detected on TCD monitoring
• This likely contributes to the higher perioperative stroke risk in women

Possible Reasons for Higher Perioperative Risk

4. Anatomical and Technical Differences

• Smaller artery diameter in women requires tailored techniques - patch angioplasty closure becomes even more important to prevent restenosis and maintain lumen size
• Eversion endarterectomy may carry different risks due to caliber differences
• The same review noted that when technique is adapted to the female anatomy, CEA and TCAR (transcarotid artery revascularization) can achieve similar procedural risk in men and women
• The formal indications for CEA are the same in women as in men - but the choice of revascularization technique and the threshold decision in asymptomatic disease must be individualized

5. Natural History Differences Affecting the Decision

• Women with carotid stenosis have a lower rate of subsequent stroke than men with the same stenosis degree
• This lower baseline risk means the number needed to treat is higher in women - surgery must be performed at a very low complication rate to yield net benefit
• Asymptomatic bruits in women do not carry the same ipsilateral stroke risk that they do in men

6. CEA vs. Carotid Stenting: Does Sex Change the Choice?

• Rockman et al. (2022) concluded that the choice between CEA, CAS, and TCAR in women should be based on the same factors as in men: risk profile, anatomy, plaque morphology, and comorbidities - with extra attention to vessel size
• Some data (including CREST) suggested CAS may be relatively less favorable in older women due to greater embolic risk from small, tortuous vessels
• A Lancet Neurology paper cited in Sabiston's specifically asked: "Should sex influence the choice between carotid stenting and carotid endarterectomy?" - reflecting ongoing debate

Summary Table

• Harrison's Principles of Internal Medicine, 22nd ed., Surgical Therapy
• Adams and Victor's Principles of Neurology, 12th ed., Asymptomatic Carotid Stenosis
• Bradley and Daroff's Neurology in Clinical Practice, Symptomatic & Asymptomatic CEA sections
• Miller's Anesthesia, 10th ed., Indications & TCD sections
• Textbook of Family Medicine 9e, Carotid Artery Stenosis
• Rockman C et al. "Carotid Interventions for Women: The Hazards and Benefits." Stroke 2022 [PMID 34983240]
• Accarino G et al. "Female sex and outcomes of symptomatic carotid stenosis revascularization." Int Angiol 2025 [PMID 40329770]